logo
  

U.S. Stocks Show Significant Turnaround After Seeing Early Weakness

wallstreet sept18 22jun22 lt

After coming under pressure early in the session, stocks have shown a significant turnaround over the course of morning trading on Wednesday. The major averages have bounced well off their lows of the session and into positive territory.

The major averages have seen further upside in recent trading, reaching new highs for the session. The Dow is up 141.60 points or 0.5 percent at 30,671.85, the Nasdaq is up 132.07 points or 1.2 percent at 11,201.37 and the S&P 500 is up 26.31 points or 0.7 percent at 3,791.10.

The rebound on Wall Street comes as traders react to Federal Reserve Chair Jerome Powell's testimony before the Senate Banking Committee.

In prepared remarks, Powell indicated the Fed plans to continue moving expeditiously to combat inflation but argued the U.S. economy is strong enough to handle tighter monetary policy.

Powell said the pace of future interest rate hikes will be dependent on incoming data and the evolving outlook for the economy and suggested the Fed will need to see "compelling evidence" that inflation is slowing before it begins to scale back its monetary policy tightening plans.

"We will make our decisions meeting by meeting, and we will continue to communicate our thinking as clearly as possible," Powell said. "Our overarching focus is using our tools to bring inflation back down to our 2 percent goal and to keep longer-term inflation expectations well anchored."

The Fed Chief said the central bank will still strive to "avoid adding uncertainty in what is already an extraordinarily challenging and uncertain time."

"The opening statement from Fed Chair Jerome Powell ahead of his Semi-annual testimony to the Senate Banking Committee this morning added little to what he said in last week's post-FOMC press conference," said Michael Pearce, Senior US Economist at Capital Economics.

He added, "But his continued emphasis on the need for 'compelling' evidence that inflation is falling suggests officials will repeat last week's larger 75bp hike at the next FOMC meeting in July."

Biotechnology stocks have shown a strong move to the upside over the course of the morning, driving the NYSE Arca Biotechnology Index up by 1.8 percent.

Considerable strength has also emerged among housing stocks, as reflected by the 1.5 percent gain being posted by the Philadelphia Housing Sector Index.

Healthcare, pharmaceutical and commercial real estate stocks have also moved notably higher, while energy stocks continue to see substantial weakness amid a steep drop by the price of crude oil.

In overseas trading, stock markets across the Asia-Pacific region moved mostly lower during trading on Wednesday. Japan's Nikkei 225 Index fell by 0.4 percent, while China's Shanghai Composite Index slumped by 1.2 percent.

Meanwhile, European stocks have climbed off their worst levels of the day but remain in the red. While the German DAX Index is down by 1.1 percent, the U.K.'s FTSE 100 Index is down by 0.9 percent and the French CAC 40 Index is down by 0.7 percent.

In the bond market, treasuries have moved sharply higher, more than offsetting the pullback seen on Tuesday. Subsequently, the yield on the benchmark ten-year note, which moves opposite of its price, is down by 15.6 basis points at 3.151 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Healthcare major Johnson & Johnson, which is in the middle of a talcum powder fiasco, said it is discontinuing talc-based JOHNSON'S Baby Powder globally in 2023. The company plans to transition to an all cornstarch-based baby powder portfolio. According to the company, the commercial decision to use cornstarch in all its baby powder products was made after conducting an assessment of its portfolio Walt Disney's streaming service Disney+ is rolling out its much-anticipated new ad-supported subscription plan for Disney+ in the U.S. as part of its bid to stem the loss and make its streaming business profitable after the services posted a hefty operating loss of more than $1 billion in the third quarter. It is also raising pricing for its bundled subscription plans with Hulu, ESPN+ and live TV. The U.S. Food and Drug Administration announced the intended availability of base powder to make around 6 million bottles of specialty formula from Mexico as part of its efforts to meet the nationwide supply shortage caused by Abbott Nutrition recall. Reckitt Nutrition/Mead Johnson Nutrition will send an initial shipment of 331 thousand pounds of base powder for PurAmino Hypoallergenic Formula.
Follow RTT